Clinical Trial Update: Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial [Phase 2]

View source ↗

Summary

A Phase 2 open-label escalating-dose trial evaluated ibogaine for alcoholism. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Ibogaine (ibogaine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Alcoholism | Phase 2 | Status: COMPLETED